CI, BSX, AET, TMO And UNH, Pushing Health Services Industry Downward

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 41 points (-0.3%) at 15,444 as of Tuesday, July 16, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 951 issues advancing vs. 1,969 declining with 95 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include DaVita HealthCare Partners ( DVA), down 2.2%, CareFusion ( CFN), down 1.4%, Grifols ( GRFS), down 1.2% and Intuitive Surgical ( ISRG), down 1.1%. A company within the industry that increased today was Stryker Corporation ( SYK), up 0.6%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.86 (-1.1%) to $75.03 on average volume. Thus far, 824,178 shares of Cigna exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $74.48-$75.86 after having opened the day at $75.83 as compared to the previous trading day's close of $75.89.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $21.7 billion and is part of the health care sector. Shares are up 42.2% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Boston Scientific ( BSX) is down $0.08 (-0.8%) to $9.49 on light volume. Thus far, 3.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 18.4 million shares. The stock has ranged in price between $9.46-$9.62 after having opened the day at $9.59 as compared to the previous trading day's close of $9.57.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $13.0 billion and is part of the health care sector. Shares are up 67.7% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Aetna ( AET) is down $1.05 (-1.6%) to $62.47 on average volume. Thus far, 1.7 million shares of Aetna exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $62.25-$63.65 after having opened the day at $63.52 as compared to the previous trading day's close of $63.52.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $20.7 billion and is part of the health care sector. Shares are up 37.2% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Thermo Fisher Scientific ( TMO) is down $0.91 (-1.0%) to $87.33 on light volume. Thus far, 560,834 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $87.23-$88.43 after having opened the day at $88.34 as compared to the previous trading day's close of $88.24.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $31.7 billion and is part of the health care sector. Shares are up 38.4% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Thermo Fisher Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $0.58 (-0.9%) to $67.04 on average volume. Thus far, 3.2 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $66.56-$67.35 after having opened the day at $67.10 as compared to the previous trading day's close of $67.62.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $69.4 billion and is part of the health care sector. Shares are up 25.4% year to date as of the close of trading on Monday. Currently there are 15 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Facebook Set For Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook Set For Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

Global Stocks Mixed, U.S. Futures Soften as Earnings, Oil, Rates Cloud Sentiment

European Automakers Gain on Reports China Mulling Auto Tariff Reduction

European Automakers Gain on Reports China Mulling Auto Tariff Reduction

Deutsche Bank Plans 'Significant' Job Cuts as Q1 Profits Slump

Deutsche Bank Plans 'Significant' Job Cuts as Q1 Profits Slump

Samsung Posts Record Q1 But Adds Cautious Voice To Smartphone Demand Forecasts

Samsung Posts Record Q1 But Adds Cautious Voice To Smartphone Demand Forecasts